Cardiovascular Disease in Developing Countries: Myths, Realities, and Opportunities Thomas A. Pearson OriginalPaper Pages: 95 - 104
Effects of Pimobendan on the L-Type Ca2+ Current and Developed Tension in Guinea-Pig Ventricular Myocytes and Papillary Muscle: Comparison with IBMX, Milrinone, and Cilostazol Kazunori MatsuiTatsuto KiyosueMakoto Arita OriginalPaper Pages: 105 - 113
Mibefradil, a T-Type and L-Type Calcium Channel Blocker, Limits Infarct Size through a Glibenclamide-Sensitive Mechanism Michaela M. MocanuShashi GadgilGary F. Baxter OriginalPaper Pages: 115 - 122
Beta-Blocker Selectivity at Cloned Human Beta1- and Beta2-Adrenergic Receptors Carol SmithMilt Teitler OriginalPaper Pages: 123 - 126
Similar Risk Reduction of Death of Extended-Release Metoprolol Once Daily and Immediate-Release Metoprolol Twice Daily During 5 Years After Myocardial Infarction Johan HerlitzMikael DellborgHans Wedel OriginalPaper Pages: 127 - 135
The Search for the Hibernating Myocardium — Have We Reached the Limit? Robert Ferrari OriginalPaper Pages: 137 - 143
Effect of Trimetazidine on Late Potentials After Acute Myocardial Infarction Ramazan ÖzdemirCemal TuncerHaldun Müderrisoğlu OriginalPaper Pages: 145 - 149
Chronic Treatment with an ACE Inhibitor, Temocapril, Lowers the Threshold for the Infarct Size–Limiting Effect of Ischemic Preconditioning Yukinaga NozawaTetsuji MiuraKazuaki Shimamoto OriginalPaper Pages: 151 - 157
Selective Tyrosine Kinase Inhibitor for the Platelet-Derived Growth Factor Receptor In Vitro Inhibits Smooth Muscle Cell Proliferation After Reinjury of Arterial Intima In Vivo Marjukka MyllärniemiJuhana FrösenPekka Häyry; OriginalPaper Pages: 159 - 168
Hyponatremia and Amlodipine Therapy Henri R. MalaterreKoobhiraj KalleeLaurence M.H. Daver OriginalPaper Pages: 171 - 172
Therapeutic Organizer (TH.OR.): A New Tool in Critical Patient Management Roberto AntonicelliMoreno CecconiEnrico Paciaroni OriginalPaper Pages: 173 - 176
